Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Aclaris Therapeutics (ACRS) Interest & Investment Income (2023 - 2025)

Historic Interest & Investment Income for Aclaris Therapeutics (ACRS) over the last 3 years, with Q3 2025 value amounting to $1.8 million.

  • Aclaris Therapeutics' Interest & Investment Income fell 863.89% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 84.6%. This contributed to the annual value of $8.0 million for FY2024, which is 653.43% down from last year.
  • According to the latest figures from Q3 2025, Aclaris Therapeutics' Interest & Investment Income is $1.8 million, which was down 863.89% from $2.0 million recorded in Q2 2025.
  • Aclaris Therapeutics' Interest & Investment Income's 5-year high stood at $2.3 million during Q3 2023, with a 5-year trough of $1.8 million in Q3 2025.
  • Moreover, its 3-year median value for Interest & Investment Income was $2.0 million (2025), whereas its average is $2.1 million.
  • In the last 5 years, Aclaris Therapeutics' Interest & Investment Income crashed by 1403.28% in 2024 and then surged by 884.42% in 2025.
  • Over the past 3 years, Aclaris Therapeutics' Interest & Investment Income (Quarter) stood at $2.2 million in 2023, then dropped by 3.93% to $2.1 million in 2024, then decreased by 13.5% to $1.8 million in 2025.
  • Its Interest & Investment Income stands at $1.8 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.2 million for Q1 2025.